I  Georgia BioBusiness Center

http://www.ovpr.uga.edu/gbbc





     Office Locations:

220 Riverbend Road
University of Georgia
Athens, GA 30602

 

Stages:

  • Early
  • Seed


 

Industries:

  • Food & Agriculture
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2000, the Georgia BioBusiness Center is a program sponsored by the University of Georgia Research Foundation (UGARF) and is in partnership with the Center for Applied Genetic Technologies (CAGT). The Georgia BioBusiness Center is currently affiliated with several startup bioscience companies with research and technology ties to UGA. The GBBC is primarily interested in companies in the biotechnology, agribusiness, biofuels, pharmaceutical, therapeutic, diagnostic, medical device or other bioscience field. Prospective companies should make a commitment to hiring between 4 and 20 employees in the Athens area within one year of assuming GBBC residency status.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Derek E. Eberhart PhD GBBC Interim Director
    Stefan Schulze Associate Director

     

    Portfolio companies include:


      Abeome
        web link


      Argent Diagnostics
        web link


      ArunA Biomedical
        web link


      Bacterial Barcodes
        web link


      BioInquire
        web link


      Evirx
        web link


      Glycoscientfic
        web link


      Glycosensors and Diagnostics
        web link


      InsectiGen
        web link


      IS3D
        web link


      Molecular Therapeutics
        web link


      Natural Science Enterprises
        web link


      Planteco Environmental Consultants
        web link


      rPeptide
        web link


      Synageva BioPharma
        web link


      ViaCyte
        web link


      Vitamin Derivatives
        web link


     

    Recent News: